The group has built four production bases of western medicine preparations, raw materials medicines, Chinese patent medicines and health foods, and has become a national comprehensive group enterprise and a national high-tech enterprise focusing on western medicine preparations and raw materials medicines, Chinese patent medicines and health foods, integrating real estate and software development.
20 1 1 year achieved sales income of 2 billion yuan and paid taxes of 1 more than 100 million yuan, ranking 69th among the top 100 pharmaceutical enterprises in China.
enterprise management
The management system of the group is perfect, the authorization is clear, the process is clear and the execution is strong;
Six-day management system (Japanese day, Japanese day sequence, Japanese day evaluation, Japanese day guide and Japanese day height), monthly performance appraisal system and year-end performance appraisal system have been implemented, and the work efficiency has been greatly improved;
A scientific supervision and feedback mechanism has been established, and management systems such as procurement, finance, production and scientific research operate efficiently and standardly.
High-quality talent team
The Group currently has 2,000 employees, more than 65% of whom have college degree or above, and come from more than 20 provinces and 100 colleges and universities.
A perfect vertical and horizontal training system has been established, and the monthly training time exceeds 10 hour.
The Group provides dormitories and housing for employees, and regularly organizes team-building activities, such as tourism, sports meetings and cultural evenings.
The marketing network is all over the country.
Disha Group adheres to the market-oriented, scientific marketing model and dynamic mechanism.
Two marketing networks have been established: a pharmaceutical marketing network focusing on Chinese and western medicine preparations, covering all terminals of high, middle and low schools nationwide, and a pharmaceutical marketing network focusing on raw materials and intermediates.
More than 5,000 hospitals across the country have established formal business relations with commercial companies at all levels, and their products cover more than 90% of the country.
Strong product research and development strength
The Group has 50 full-time R&D personnel, Shandong Endocrine Medicine Engineering Technology Research Center and Shandong Enterprise Technology Center, and undertakes more than ten innovative projects above the municipal level every year, and is actively preparing to establish a national engineering technology research center.
Product technology is strictly controlled, technology is constantly innovated and improved, and product quality is greatly improved.
It has the ability to independently research and develop the first, second and third class national new drugs, and can research and develop 10-20 new products and launch 8- 10 new products every year.